Rhumbline Advisers Purchases 1,447 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Rhumbline Advisers increased its position in Huron Consulting Group Inc. (NASDAQ:HURN) by 5.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,280 shares of the business services provider’s stock after buying an additional 1,447 shares during the quarter. Rhumbline Advisers owned 0.15% of Huron Consulting Group worth $3,770,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of HURN. Summit Investment Advisors Inc. lifted its position in Huron Consulting Group by 5.5% in the fourth quarter. Summit Investment Advisors Inc. now owns 1,838 shares of the business services provider’s stock valued at $228,000 after purchasing an additional 96 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in Huron Consulting Group by 3.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 4,039 shares of the business services provider’s stock valued at $502,000 after purchasing an additional 121 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in Huron Consulting Group by 27.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider’s stock valued at $71,000 after purchasing an additional 122 shares during the last quarter. Hillsdale Investment Management Inc. lifted its position in Huron Consulting Group by 0.5% in the fourth quarter. Hillsdale Investment Management Inc. now owns 34,060 shares of the business services provider’s stock valued at $4,232,000 after purchasing an additional 160 shares during the last quarter. Finally, Keybank National Association OH lifted its position in Huron Consulting Group by 4.2% in the fourth quarter. Keybank National Association OH now owns 4,120 shares of the business services provider’s stock valued at $512,000 after purchasing an additional 167 shares during the last quarter. Institutional investors own 93.90% of the company’s stock.

Insider Buying and Selling at Huron Consulting Group

In related news, Director James H. Roth sold 8,641 shares of the business’s stock in a transaction on Wednesday, March 26th. The stock was sold at an average price of $142.38, for a total transaction of $1,230,305.58. Following the completion of the transaction, the director now owns 47,638 shares in the company, valued at $6,782,698.44. The trade was a 15.35% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joy Brown sold 668 shares of the business’s stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $149.74, for a total value of $100,026.32. Following the transaction, the director now owns 8,896 shares of the company’s stock, valued at approximately $1,332,087.04. The trade was a 6.98% decrease in their position. The disclosure for this sale can be found here. Insiders sold 18,951 shares of company stock worth $2,758,473 in the last quarter. 2.15% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts recently commented on HURN shares. Truist Financial upped their target price on Huron Consulting Group from $165.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday, March 4th. Benchmark restated a “buy” rating and set a $165.00 target price on shares of Huron Consulting Group in a report on Wednesday, March 26th. William Blair restated an “outperform” rating on shares of Huron Consulting Group in a report on Wednesday, March 26th. Barrington Research upped their target price on Huron Consulting Group from $167.00 to $173.00 and gave the company an “outperform” rating in a report on Monday, May 5th. Finally, Wall Street Zen cut Huron Consulting Group from a “buy” rating to a “hold” rating in a research note on Friday, May 2nd. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $170.75.

Huron Consulting Group Stock Down 1.4%

Shares of HURN opened at $134.70 on Friday. The business’s 50 day moving average is $143.67 and its 200 day moving average is $135.76. The company has a market capitalization of $2.32 billion, a PE ratio of 29.28 and a beta of 0.30. Huron Consulting Group Inc. has a 12-month low of $94.31 and a 12-month high of $155.00. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82.

Huron Consulting Group (NASDAQ:HURN) last issued its earnings results on Tuesday, April 29th. The business services provider reported $1.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.52. The company had revenue of $404.14 million for the quarter, compared to the consensus estimate of $389.27 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. During the same quarter last year, the company earned $1.23 EPS. Research analysts expect that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.